Tongue squamous cell carcinoma
1 paper studies it
- Cells1
Trial sponsors
1 trialPhase 2/3686 people
1 trialPhase 269 people
Latest
Cell Communication and Signaling
The Src family kinase inhibitor drug Dasatinib and glucocorticoids display synergistic activity against tongue squamous cell carcinoma and reduce MET kinase activity
Experiments in human cellsGlucocorticoids